LTI-01 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pleural Effusion
Conditions
Pleural Effusion
Trial Timeline
Sep 26, 2020 → Jul 28, 2022
NCT ID
NCT04159831About LTI-01 + Placebo
LTI-01 + Placebo is a phase 2 stage product being developed by Rein Therapeutics for Pleural Effusion. The current trial status is completed. This product is registered under clinical trial identifier NCT04159831. Target conditions include Pleural Effusion.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04159831 | Phase 2 | Completed |
Competing Products
20 competing products in Pleural Effusion